Details

Autor(en) / Beteiligte

• Pickering, Matthew C.
• D'Agati, Vivette D.
• Nester, Carla M.
• Smith, Richard J.
• Haas, Mark
• Appel, Gerald B.
• Alpers, Charles E.
• Bajema, Ingeborg M.
• Bedrosian, Camille
• Braun, Michael
• Doyle, Mittie
• Fakhouri, Fadi
• Fervenza, Fernando C.
• Fogo, Agnes B.
• Frémeaux-Bacchi, Véronique
• Gale, Daniel P.
• Goicoechea de Jorge, Elena
• Griffin, Gene
• Harris, Claire L.
• Michael Holers, V.
• Johnson, Sally
• Lavin, Peter J.
• Medjeral-Thomas, Nicholas
• Paul Morgan, B.
• Nast, Cynthia C.
• Noel, Laure-Hélène
• Keith Peters, D.
• Rodríguez de Córdoba, Santiago
• Servais, Aude
• Sethi, Sanjeev
• Song, Wen-Chao
• Tamburini, Paul
• Thurman, Joshua M.
• Zavros, Michael
• Terence Cook, H.

Titel

C3 glomerulopathy: consensus report

Ist Teil von

• Kidney international, 2013-12, Vol.84 (6), p.1079-1089

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2013

Link zum Volltext

Quelle

Free E-Journal (出版社公開部分のみ）

Beschreibungen/Notizen

• C3 glomerulopathy is a recently introduced pathological entity whose original definition was glomerular pathology characterized by C3 accumulation with absent or scanty immunoglobulin deposition. In August 2012, an invited group of experts (comprising the authors of this document) in renal pathology, nephrology, complement biology, and complement therapeutics met to discuss C3 glomerulopathy in the first C3 Glomerulopathy Meeting. The objectives were to reach a consensus on: the definition of C3 glomerulopathy, appropriate complement investigations that should be performed in these patients, and how complement therapeutics should be explored in the condition. This meeting report represents the current consensus view of the group.